AA. Kusch, GE. Fedoseeva; OA. Kiseleva; AV. Zelenin, [Comparative analysis of mechanisms of biological action of antibiotics from the aureolic acid group and their derivatives]., in Antibiotiki, vol. 17, n. 6, Giu 1972, pp. 504-13, PMID5045917.
S. Majee, A. Chakrabarti, Membrane interaction of an antitumor antibiotic, mithramycin, with anionic phospholipid vesicles., in Biochem Pharmacol, vol. 57, n. 9, Mag 1999, pp. 981-7, PMID10796068.
S. Kofman, TJ. Medrek; RW. Alexander, Mithramycin in the treatment of embryonal cancer., in Cancer, vol. 17, Lug 1964, pp. 938-48, PMID14179556.
H. Gremmel, W. Schulte-Brinkmann, [Malignant testicular tumors. Results of the treatment using surgery, ionizing radiation and cytostatic agents]., in Radiologe, vol. 4, Lug 1964, pp. 209-20, PMID14250288.
JL. Stumpf, Pharmacologic management of Paget's disease., in Clin Pharm, vol. 8, n. 7, Lug 1989, pp. 485-95, PMID2666012.
RG. Benedetti, KJ. Heilman; PA. Gabow, Nephrotoxicity following single dose mithramycin therapy., in Am J Nephrol, vol. 3, n. 5, pp. 277-8, PMID6227249.
ME. MacCara, Extravasation: a hazard of intravenous therapy., in Drug Intell Clin Pharm, vol. 17, n. 10, Ott 1983, pp. 713-7, PMID6628223.
PF. D'Arcy, Reactions and interactions in handling anticancer drugs., in Drug Intell Clin Pharm, vol. 17, n. 7-8, pp. 532-8, PMID6872848.
GP. Kaijser, WJ. Underberg; JH. Beijnen, The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs., in Pharm Weekbl Sci, vol. 12, n. 6, Dic 1990, pp. 228-35, PMID2091018.